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ABSTRACT 
Premenstrual syndrome (PMS) is a common disorder of young and middle-aged women 
characterized by cyclic occurrence in the luteal phase of the menstrual cycle of a combination of 
distressing physical, psychological and behavioral changes of sufficient severity to result in 
deterioration of inter- personal relationships; which remit upon onset or immediately after 
menstruation. PMS is due to doshic imbalance and impairment of satwa. Objective of study is to find 
out the effect of Punarnavadi kashayam and Aswagandha choornam in Premenstrual syndrome. 
Study design was interventional, pre and posttest with a sample size of 20. Females of age group 
20-35 years with PMS fulfilling the American College of Obstetrics and Gynecology criteria of PMS 
were selected. Punarnavadi Kashayam in the dose of 48 ml bid, 30 minutes before food and 
Aswagandha choorna in the dose of 3 gm. bid along with Kashaya. Administration of drug started 14 
days before menstruation and was continued till fourth day of menstruation for three consecutive 
cycles. Follow up was done for next two consecutive cycles. Patient was assessed on fifth day of 
menstruation during study period and follow up period. The research drug had shown effectiveness 
in the treatment of depressive effect, anxiety, fatigue, irritation, depressive thoughts, pain, appetite 
changes, sleep changes, bloating assessed by premenstrual scale. Both drugs showed effectiveness 
in normalizing serum sodium and serum potassium levels. Associated premenstrual complaints 
also subsided. Study concluded that Punarnavadi kashaya and Aswagandha choorna is very much 
effective in treating Premenstrual syndrome. 
KEYWORDS: Premenstrual Syndrome; Punarnavadi kashaya; Aswagandha choorna; ACOG Criteria. 
INTRODUCTION 
 Premenstrual Syndrome is a common 
disorder of young and middle aged women 
characterized by cyclic occurrence in the luteal phase 
of menstrual cycle of a combination of distressing 
physical, psychological and behavioural changes of 
sufficient severity to result in deterioration of 
interpersonal relationships and/or interfere with 
normal activities which subsides after menstruation. 
A thorough study of Ayurvedic classics doesn’t reveal 
any condition similar to PMS. PMS can be considered 
as an event occurring in Rithuvyateeta Kala and it 
may be due to imbalance of Tridosha. It is estimated 
that PMS has 40 million suffers and more than 5 
million suffers required medical treatment[1]. Women 
are affected irrespective of socioeconomic status, 
race or cultural background. In the modern world 
women has to manage the double role both as a 
house wife and as a professional. Women with PMS 
reported greater number of days with impairment in 
routine work in comparison with women without 
PMS, indicating that PMS leads to substantial loss in 
normal activities, family problems, and increased 
work absenteeism. Only limited study has been done 
on Ayurveda to find out efficacy of Ayurvedic 
formulations on PMS. The conventional management 
of PMS is related with hormones, antidepressants, 
SSRI, having so many side effects such as nausea, 
headache, decreased orgasm, early menopause, 
insomnia. Therefore a management that would help 
to reduce the symptoms of PMS and to avoid side 
effects will be a boon to women hood. Punarnavadi 
Kashayam mentioned in Bhaisajya Ratnavali and 
Aswagandha Choornam is selected. It is effective, 
easily administrable, and cost effective, without any 
untoward side effects. By this we can contribute a 
safer drug to the medical field for the benefit of 
patients, which may devoid of adverse effects and can 
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project Ayurveda into main stream in treatment of 
PMS. 
AIMS AND OBJECTIVES OF STUDY 
To find out the effect of Punarnavadi Kashayam and 
Aswagandha Choornam in Premenstrual syndrome. 
MATERIALS AND METHODS  
1. Study Design 
Pre and Post Interventional study without 
control.  
2. Study Setting 
Outpatient department and Inpatient 
department, Govt. Ayurveda College Hospital for 
Women and Children, Poojappura, 
Thiruvananthapuram. 
3. Study Population 
Females of age group 20-35 yrs. with PMS 
attending the outpatient department and 
Inpatient department fulfilling the American 
College of Obstetrics and Gynecology criteria of 
PMS. 
4. Inclusion Criteria 
Females of age group 20-35yrs diagnosed as PMS. 
5. Exclusion Criteria 
a) Patients with irregular menstruation 
b) Patients undergoing prolonged medication 
c) Known hypertensive patients 
d) Hypothyroidism 
e) Concomitant psychotherapy 
f) Pelvic inflammatory disease 
g) Underlying pathological conditions of breast. 
6. Sample Size: 20 
7. Sampling Technique 
Consecutive cases satisfying inclusion criteria till 
sample size is attained. 
8. Data Collection 
 Primary data will be collected through American 
College of Obstetrics and Gynecology Criteria, 
case proforma. 
9. Study Tool 
American College of Obstetrics and Gynecology 
Criteria, Case proforma, Symptom assessment by 
PMS scale. 
10. Procedure  
Patients eligible for study was selected from 
study setting as per inclusion criteria. Primary 
data was collected using American College of 
Obstetrics and Gynecology criteria and case 
proforma. Study was conducted in a single group 
and clinical symptoms of patients were assessed 
before starting the treatment. 
 
Drug administration   
The ingredients of Punarnavadi kashayam 
was purchased, powdered and made into drug 
packets having 48gm of coarse powder each. The 
finely powdered Aswagandha choorna was made into 
drug packets having 3 gm. of fine powder each. Mode 
of preparation was well explained to the patients, 
along with written advice in their local language. 
Punarnavadi Kashayam was given in the dose of 48ml 
bid, half an hour before food. Aswagandha Choorna 
was given in the dose of 3 gm. bid along with 
Kashaya. Pathya Ahara and Vihara were 
recommended. 
Duration of administration 
Administration of drug started 14 days before 
menstruation and was continued till fourth day of 
menstruation for three consecutive cycles. 
Follow up 
Follow up was done for next two consecutive cycles. 
Assessment  
Patients were advised to report on fifth day of 
menstrual cycle. Patient was assessed on fifth day of 
menstruation in all three cycles during study period 
and next two cycles during follow up period. 
11. Outcome Variable 
Change in level of symptoms such as depressive 
effect, anxiety, fatigue, irritation, depressive thoughts, 
pain, appetite changes, sleep changes, bloating were 
assessed by Premenstrual syndrome scale. Blood 
serum level of sodium, potassium was assessed on 
21st day of first menstrual cycle and on third 
menstrual cycle during study period. 
Parameters for Assessment 
Outcome variables are the efficacy 
measurements of study. 
Assessment 
Change in level of symptoms such as 
depressive effect, anxiety, fatigue, irritation, 
depressive thoughts, pain, appetite changes, sleep 
changes, bloating were assessed by Premenstrual 
syndrome scale. Blood serum level of sodium, 
potassium were assessed on 21st day of first 
menstrual cycle and on third menstrual cycle during 
study period. 
Statistical Analysis 
Changes in level of symptoms such as 
depressive effect, anxiety, fatigue, irritation, 
depressive thoughts, pain, appetite changes, sleep 
changes, bloating was assessed by Wilcoxon’s signed 
rank test. Total symptom score of PMS Scale was 
assessed by paired t test. Changes in Serum level of 
Sodium and Potassium was assessed by Paired t test.  
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Ethical Consideration 
The study was approved by Institutional 
Ethics Committee and certificate of consent from 
subjects was obtained prior to study.  
RESULTS  
 Data Related to Socio Demography: Majority of 
patients (50%) were in the age group 31-35 
years; (60%) were from rural area; (50%) 
graduated; (50%) office staff. (85%) married; 
(50%) middle class. 
 Data Related to Personal History: Majority of 
patients (65%) were having sedentary life style; 
(80%) were non vegetarians; (60%) were 
preferring sweet/sour/salty taste; (60%) were 
having irregular food intake; (60%) habit of 
coffee intake; (50%) obese 
 Data Related to Satwa and Prakriti. (60%) 
were having Madhyama satwa; (50%) Kapha Vata 
Prakriti; (40%) Vatapitta; (10%) Pitta Kapha. 
 Data related to Family History: (50%) were 
having familial tendency. 
 Percentage Distribution According to 
Premenstrual Symptoms: Headache (90%), 
Breast tenderness/swelling (95%), Sugar/salt 
craving (70%), Swelling of extremities (85%), 
Acne (95%), Anger (75%), Mood swing (65%), 
Sexual disturbance (50%), joint pain (75%), 
Social withdrawal (65%). 
Data Related to Effectiveness of Treatment 
Table 1: Effectiveness of Treatment on Depressive Effect 
  
Depressive effect    
Total 
Wilcoxon signed rank 
test (comparison with BT) Never Rarely Sometimes Often Always 
N % N % N % N % N % N z p 
BT 0 0 1 5.0 3 15.0 11 55.0 5 25.0 20    
AT1 0 0 4 20.0 8 40.0 8 40.0 0 0 20 3.771 <0.001 
AT2 1 5.0 9 45.0 6 30.0 4 20.0 0 0.0 20 4.093 <0.001 
AT3 6 30.0 8 40.0 6 30.0 0 0.0 0 0 20 4.128 <0.001 
AF1 14 70.0 6 30.0 0 0.0 0 0 0 0 20 4.058 <0.001 
AF2 18 90.0 2 10.0 0 0.0 0 0 0 0 20 4.005 <0.001 
Table 2: Effectiveness of Treatment on Anxiety 
  
Anxiety    
Total 
Wilcoxon signed rank 
test (comparison with BT) Never Rarely Sometimes Often Always 
N % N % N % N % N % N z p 
BT 0 0.0 1 5.0 5 25.0 10 50.0 4 20.0 20 
 
 
AT1 1 5.0 4 20.0 11 55.0 4 20.0 0 0.0 20 4.146 <0.001 
AT2 1 5.0 13 65.0 4 20.0 2 10.0 0 0.0 20 4.028 <0.001 
AT3 8 40.0 7 35.0 5 25.0 0 0.0 0 0 20 4.006 <0.001 
AF1 14 70.0 5 25.0 1 5.0 0 0.0 0 0 20 4.005 <0.001 
AF2 16 80.0 4 20.0 0 0.0 0 0 0 0 20 4.034 <0.001 
Table 3: Effectiveness of Treatment on Fatigue 
  
Fatigue   
Total 
Wilcoxon signed rank 
test (comparison with BT) Never Rarely Sometimes Often Always 
N % N % N % N % N % N z p 
BT 0 0.0 0 0.0 6 30.0 9 45.0 5 25.0 20 
 
 
AT1 0 0.0 2 10.0 13 65.0 5 25.0 0 0 20 3.771 <0.001 
AT2 0 0.0 11 55.0 6 30.0 3 15.0 0 0 20 3.954 <0.001 
AT3 6 30.0 9 45.0 5 25.0 0 0.0 0 0 20 3.897 <0.001 
AF1 12 60.0 7 35.0 1 5.0 0 0.0 0 0 20 4.005 <0.001 
AF2 17 85.0 3 15.0 0 0.0 0 0 0 0 20 4.006 <0.001 
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Table 4: Effectiveness of Treatment on Irritability 
  
Irritability   
Total 
Wilcoxon signed rank 
test (comparison with BT) Never Rarely Sometimes Often Always 
N % N % N % N % N % N z p 
BT 0 0.0 0 0.0 3 15.0 11 55.0 6 30.0 20 
 
 
AT1 0 0 2 10.0 9 45.0 8 40.0 1 5.0 20 3.638 <0.001 
AT2 0 0.0 5 25.0 11 55.0 3 15.0 1 5.0 20 3.782 <0.001 
AT3 4 20.0 11 55.0 4 20.0 1 5.0 0 0.0 20 4.055 <0.001 
AF1 11 55.0 7 35.0 1 5.0 1 5.0 0 0.0 20 3.970 <0.001 
AF2 15 75.0 4 20.0 1 5.0 0 0.0 0 0 20 4.011 <0.001 
Table 5: Effectiveness of Treatment on Depressive Thoughts 
  
Depressive thoughts   
Total 
Wilcoxon signed rank 
test (comparison with BT) Never Rarely Sometimes Often Always 
N % N % N % N % N % N z p 
BT 0 0.0 0 0.0 7 35.0 9 45.0 4 20.0 20 
 
 
AT1 0 0.0 6 30.0 7 35.0 6 30.0 1 5.0 20 3.873 <0.001 
AT2 0 0 9 45.0 7 35.0 4 20.0 0 0.0 20 3.947 <0.001 
AT3 5 25.0 9 45.0 6 30.0 0 0.0 0 0 20 3.983 <0.001 
AF1 13 65.0 6 30.0 1 5.0 0 0.0 0 0 20 4.008 <0.001 
AF2 16 80.0 4 20.0 0 0.0 0 0 0 0 20 4.005 <0.001 
Table 6: Effectiveness of Treatment on Pain 
  
Pain   
Total 
Wilcoxon signed rank 
test (comparison with BT) Never Rarely Sometimes Often Always 
N % N % N % N % N % N z p 
BT 0 0.0 0 0.0 3 15.0 6 30.0 11 55.0 20 
 
 
AT1 0 0.0 3 15.0 4 20.0 12 60.0 1 5.0 20 4.123 <0.001 
AT2 0 0.0 6 30.0 10 50.0 4 20.0 0 0 20 4.038 <0.001 
AT3 6 30.0 9 45.0 4 20.0 1 5.0 0 0.0 20 3.970 <0.001 
AF1 14 70.0 3 15.0 3 15.0 0 0.0 0 0 20 3.976 <0.001 
AF2 15 75.0 5 25.0 0 0.0 0 0 0 0 20 3.985 <0.001 
Table 7: Effectiveness of treatment on appetite changes 
  
Appetite change   
Total 
Wilcoxon signed rank 
test (comparison with BT) Never Rarely Sometimes Often Always 
N % N % N % N % N % N z p 
BT 1 5.0 1 5.0 7 35.0 5 25.0 6 30.0 20 
 
 
AT1 1 5.0 7 35.0 7 35.0 4 20.0 1 5.0 20 3.690 <0.001 
AT2 2 10.0 10 50.0 5 25.0 3 15.0 0 0.0 20 3.727 <0.001 
AT3 6 30.0 11 55.0 3 15.0 0 0.0 0 0 20 3.775 <0.001 
AF1 16 80.0 3 15.0 1 5.0 0 0.0 0 0 20 3.869 <0.001 
AF2 17 85.0 3 15.0 0 0.0 0 0 0 0 20 3.880 <0.001 
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Table 8: Effectiveness of Treatment on Sleep Changes 
  
Sleep change   
Total 
Wilcoxon signed rank 
test (comparison with BT) Never Rarely Sometimes Often Always 
N % N % N % N % N % N z p 
BT 1 5.0 0 0.0 10 50.0 6 30.0 3 15.0 20 
 
 
AT1 1 5.0 9 45.0 7 35.0 2 10.0 1 5.0 20 3.900 <0.001 
AT2 4 20.0 11 55.0 3 15.0 2 10.0 0 0.0 20 3.954 <0.001 
AT3 10 50.0 8 40.0 1 5.0 1 5.0 0 0.0 20 4.014 <0.001 
AF1 18 90.0 1 5.0 1 5.0 0 0.0 0 0 20 3.934 <0.001 
AF2 18 90.0 1 5.0 1 5.0 0 0.0 0 0 20 3.934 <0.001 
Table 9: Effectiveness of Treatment on Bloating 
  
Bloating   
Total 
Wilcoxon signed rank 
test (comparison with BT) Never Rarely Sometimes Often Always 
N % N % N % N % N % N z p 
BT 0 0.0 0 0.0 3 15.0 8 40.0 9 45.0 20 
 
 
AT1 0 0.0 4 20.0 7 35.0 8 40.0 1 5.0 20 3.879 <0.001 
AT2 3 15.0 7 35.0 6 30.0 4 20.0 0 0.0 20 4.008 <0.001 
AT3 7 35.0 7 35.0 5 25.0 1 5.0 0 0.0 20 4.026 <0.001 
AF1 12 60.0 4 20.0 4 20.0 0 0.0 0 0 20 3.994 <0.001 
AF2 14 70.0 6 30.0 0 0.0 0 0.0 0 0.0 20 4.029 <0.001 
Table 10: Effectiveness of treatment on Total Symptom Score 
  N 
Total symptom score  Paired 
comparison 
Paired Differences paired t test 
Mean sd Mean sd t p 
BT 20 35.70 4.92           
AT1 20 28.10 4.81 BT - AT1 7.60 2.95 11.541 <0.001 
AT2 20 23.40 5.66 BT - AT2 12.30 4.09 13.441 <0.001 
AT3 20 17.45 5.39 BT - AT3 18.25 5.38 15.173 <0.001 
AF1 20 12.55 4.77 BT - AF1 23.15 4.82 21.500 <0.001 
AF2 20 10.80 2.89 BT - AF2 24.90 4.20 26.488 <0.001 
Table 11: Effectiveness of Treatment on Serum Sodium Level 
  N 
Sodium level  Paired Differences Paired t test 
Mean sd Mean sd t p 
BT 20 142.45 1.468 3.800 
  
1.105 
  
15.379 
  
<0.001 
  AT 20 138.65 1.496 
Table 12: Effectiveness of Treatment on Serum Potassium Level 
  N 
Potassium level  Paired Differences Paired t test 
Mean sd Mean sd t p 
BT 20 4.03 .212 .420 
  
.151 
  
-12.457 
  
<0.001 
  AT 20 4.45 .209 
 
 
Akhila M et al. Effect of Punarnavadi Kasahaya and Aswagandha Choorna in Premenstrual Syndrome 
     Available online at: http://ijapr.in  53 
DISCUSSION 
Conceptual Discussion 
Premenstrual syndrome is having distressing 
physical, psychological and behavioral symptoms, not 
caused by organic disease, which regularly recur 
during same phase of menstrual cycle and which 
significantly regress or disappear during the 
remainder of the cycle. Approximately 80% of all 
women of reproductive age experience psychological, 
behavioral and physical changes associated with the 
premenstrual phase[2]. PMS have a very strong 
negative impact on women’s family, work and social 
life. It hampers women’s relationship with their 
spouse, children and community. More than 150 
different symptoms have been attributed to PMS. 
Some of the major distressing physical symptoms 
includes headache, breast tenderness and swelling, 
bloating, pain, swelling of extremities, infection and 
fatigue. Behavioral symptoms comprises, reduced 
cognitive abilities, sexual disturbances, social 
withdrawal, insomnia, food cravings, appetite 
changes. Psychological symptoms are the most 
common symptoms for seeking help including mainly 
tearfulness, irritability, mood swing, anxiety, 
depression, confusion, anger. PMS is found to have 
multiple pathophysiological involvements. Ovarian 
sex steroid level fluctuation is the major culprit in 
causing physical, psychological and behavioral 
symptoms of PMS, i.e., alteration in level of estrogen 
progesterone ratio and diminished progesterone 
level. Variation in CNS neurotransmitters such as 
serotonergic dysregulation, low-level GABA, 
adrenergic dysregulation is responsible for 
psychological symptoms. The interaction of sex 
steroids with RAAS, alters fluid and electrolyte 
balance resulting in fluid retention symptoms. The 
role of genetic predisposition, Dietary nutritional 
insufficiency, improper lifestyle and stress are 
unavoidable factors leading to PMS. PMS is a 
reflection of sociocultural misbelief and unhealthy 
mental status. 
Ayurveda classics doesn’t reveal any 
condition similar to PMS. Tridoshas play equal role in 
etiopathology of PMS. Considering role of Pancha 
vayu, the psychological and behavioural symptoms 
can be attributed to Prana vayu. Reduced cognitive 
abilities, forgetfulness, changes in complexion, 
fatigue can be attributed to Udana vayu dushti. 
Samana vata vitiation hampers Agni leading to 
appetite changes. Vyana vata vitiation leads to 
improper nourishment and alters sound mind. Apana 
vata vitiation impairs normal menstruation. Dooshita 
Pitta impairs agni leading to appetite changes. 
Dizziness, insomnia, anger and irritability can be due 
to Prakupita pitta. Sadhaka pitta impairment causes 
forgetfulness, reduced cognitive abilities .Changes in 
skin and hair can be attributed to Brajaka pitta. The 
symptoms of fluid retention, increased weight gain, 
sleep changes, fatigue, and infection can be attributed 
to Kledaka and Tarpaka kapha. 
 Samanya nidanas of Yoniroga such as 
Mithyaachara, Pradushta artava, Beeja dushti and 
Daiva are also inevitable factors leading to PMS. 
Under Mithyaachara, abnormalities of dietetics, 
lifestyle changes, mental and physical stress can be 
considered. Hormonal changes can be considered 
under Pradushta artava. The role of genetic factors 
and idiopathic factors also be considered. Dosha 
Dushti nidanas can be considered as Vishesha nidanas 
leading to PMS. 
Premenstrual syndrome is a pathology 
occurring in Rithuvyateeta kala. There will be Vata 
prakopa, Pitta in Chaya avastha and Kapha in Ksheena 
avastha. Mithyaahara vihara, Pradushtaaartava, Beeja 
dosha and Daiva may be the factors predisposing 
PMS. This will lead to Tridosha kopa along with 
Agnimandhya leading to Srotodushti. This along with 
stressful life of modern era predisposes PMS 
especially in Heena Satwa individuals and having 
Tamasa, Rajasa prakriti. 
Tridosha dusti along with Aama formation, 
leading to Srotorodha and Srotodushti in Rasa, Rakta 
mamsa, Asthi and Artavavaha occurs. The above 
factors along with involvement of Manovaha srotas 
causes PMS especially in Rajasa tamasa individuals. 
Therefore treatment should aim at normalizing 
Tridoshas and Manovaha srotas. 
Discussion on Data Related to Socio Demography 
In the present study, the incidence of PMS 
was higher in women between the age group 31-35 
years. Studies done have proven PMS is more 
prevalent in this age group as they may be afflicted 
with more familial and work stress leading to 
hormonal imbalance, which is considered as a major 
causative factor in PMS[3]. Majority of the patients 
were having graduation, may be because of low 
tolerance for stress, unsatisfactory diet and habits 
leading to PMS. Majority of the patients were office 
staffs, due to stress and strain in work, family, 
Vegadharana, irregular food habits, and sedentary 
life style attributes to PMS. Majority of patients were 
married, as the stress and strain in family, increased 
responsibilities may be the factor leading to PMS. 
Majority of patients were from middle class, as the 
stress and strain in family, may be the factor leading 
to PMS. 
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Discussion on Data Related to Personal History 
Majority of the patients is having sedentary 
life style, which is one among major cause of PMS. 
Exercise increases endorphin and serotonin level, 
proved to have psychological and physiological 
benefits which helps to improve PMS symptoms, 
especially mood swings, depression and fatigue. 
Majority of patients were having mixed diet. Excess 
intake of junk foods, especially beef, meat, refined 
sugar and dairy products are among major 
predisposing factor of PMS. Majority of patients were 
preferring sweet/sour/salt taste, which had been 
proven as a risk factor of PMS. Studies proved that 
excess intake of this will lead to fluid retention 
symptoms, lethargy, fatigue and anxiety[4]. Majority of 
were having irregular food intake, which causes 
general ill-health and nutritional deficiency. Dietary 
deficiency of vitamin, magnesium and calcium are 
proved to be the risk factor leading to PMS. Majority 
of patients have the habit of coffee intake. Studies 
have proven excess of caffeine intake as risk factor 
leading to PMS. Excess amount can result in caffeine 
intoxication causing psychomotor agitation, thought 
disorder. Majority of patients were obese. Increased 
BMI was found to be a risk factor in causing PMS. 
60% of the patients were found to anxious 
/depressed[5]. Stress is considered as one among the 
major risk factor of PMS by causing hormonal 
imbalance. Chronic stress can cause an increase in 
adrenal hormones and ACTH that leads to sodium 
water retention. Craving can also occur during the 
time of stress and worsen the situation resulting in 
feeling low, fatigue, heart pounding and headache.  
Discussion on Data Related to Satwa and Prakrit 
 Majority of patients is having Madhyama 
satwa, as stress is considered as one among the major 
risk factor of PMS by causing hormonal imbalance. 
50% of patients were having Kaphavata and 40% 
having Vatapitta prakruti. It substantiate unavoidable 
role of Tridosha in pathogenesis of disease. 
Discussion on Data Related to Effectiveness of 
Treatment 
Depressive Effect: Before treatment 55% of patients 
had often, 25% had always and 15% had sometimes 
depressive effect .After treatment it was reduced to 
0% and treatment effect was maintained during 
follow up period. A highly significant p value less 
than 0.001 is obtained after treatment which 
indicates treatment is highly effective in reducing 
depressive effect. (Table No. 1) 
Anxiety: Before treatment 5% had rarely score, 0% 
had never score. After follow up 80% had come to 
never score and 20% to rarely score. Before 
treatment 50% had always, 25% had sometimes and 
20% had always anxiety. This was reduced to 0% 
after treatment and treatment effect was maintained 
during follow up period. A highly significant p value 
less than 0.001 is obtained after treatment which 
indicates treatment is highly effective in reducing 
anxiety. (Table No. 2) 
Fatigue: Before treatment 0% had rarely score and 
never score. After follow up 85% had come to never 
score and 15% to rarely score .Before treatment 45% 
had often, 30% had sometimes and 25% had always 
anxiety. This was reduced to 0% after treatment and 
treatment effect was maintained during follow up 
period. A highly significant p value less than 0.001 is 
obtained after treatment which indicates treatment is 
highly effective in reducing fatigue. (Table No.3) 
Irritability: Before treatment 0% had rarely score 
and never score. After follow up 85% had come to 
never score and 15% to rarely score .Before 
treatment 45% had often, 30% had sometimes and 
25% had always anxiety. This was reduced to 0% 
after treatment and treatment effect was maintained 
during follow up period. A highly significant p value 
less than 0.001 is obtained after treatment which 
indicates treatment is highly effective in reducing 
irritability. (Table No.4) 
Depressive Thoughts: Before treatment 0% had 
rarely score and never score. After follow up 80% 
had come to never score and 20% to rarely score. 
Before treatment 45% had often, after treatment 
reduced to 5% and after follow up became 0%. 
Before treatment 35% had sometimes and 20% had 
always anxiety. This was reduced to 0% after 
treatment and treatment effect was maintained 
during follow up period. A highly significant p value 
less than 0.001 is obtained after treatment which 
indicates treatment is highly effective in reducing 
depressive thoughts. (Table No.5) 
Pain: Before treatment 0% had rarely score and 
never score. After follow up 75% had come to never 
score and 25% to rarely score. Before treatment 55% 
had always and 30% had often pain. This was 
reduced to 0% after treatment and treatment effect 
was maintained during follow up period. A highly 
significant p value less than 0.001 is obtained after 
treatment which indicates treatment is highly 
effective in reducing pain.(Table No.6) 
Appetite changes: Before treatment 5% had rarely 
score and never score. After follow up 85% had come 
to never score and 15% to rarely score. Before 
treatment 35% had often, after treatment reduced to 
5% and after follow up became 0%. Before treatment 
30% had always and 25% had often appetite changes. 
This was reduced to 0% after treatment and 
treatment effect was maintained during follow up 
period. A highly significant p value less than 0.001 is 
obtained after treatment which indicates treatment is 
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highly effective in reducing appetite changes. (Table 
No.7) 
Sleep changes: Before treatment 5% had rarely 
score and never score. After follow up 90% had come 
to never score and 5% to rarely score. Before 
treatment 10% had often, after treatment reduced to 
5% and after follow up became 5%. Before treatment 
30 % had often and 15% had always sleep changes. 
This was reduced to 0% after treatment and 
treatment effect was maintained during follow up 
period. A highly significant p value less than 0.001 is 
obtained after treatment which indicates treatment is 
highly effective in reducing sleep changes. (Table 
No.8) 
Bloating: Before treatment 0% had rarely score and 
never score. After follow up 70% had come to never 
score and 50% to rarely score. Before treatment 15% 
had sometimes, after treatment reduced to 20% and 
after follow up became 0%. Before treatment 40 % 
had often and 45% had always bloating. This was 
reduced to 0% after treatment and treatment effect 
was maintained during follow up period. A highly 
significant p value less than 0.001 is obtained after 
treatment which indicates treatment is highly 
effective in reducing bloating. (Table No.9) 
Total Symptom Score: Before treatment total 
symptom score was 35.70 which were reduced to 
17.45 after the treatment and to 10.80 after follow 
up. So there is reduction in total symptom score. As 
per Paired t test, we have statistically highly 
significant p value <0.001, which reveals that the 
treatment is effective in reducing total symptom 
score of PMS Scale. (Table No.10) 
Serum Sodium and Potassium Level: In the 
pathophysiology of PMS, there will be an increase in 
serum sodium level and decrease in serum potassium 
level. The mean value of Serum Sodium level was 
142.45 before treatment and it was reduced to 
138.65 after treatment. As per Paired t test we have 
statistically highly significant p value <0.001, which 
reveals that the treatment is effective in reducing 
Serum Sodium level. The mean value of Serum 
Potassium level was 4.03 before treatment and it was 
increased to 4.45 after treatment. As per Paired t test 
we have statistically highly significant p value <0.001, 
which reveals that the treatment is effective in 
increasing Serum Potassium level. (Table No.11) 
Associated Premenstrual symptoms 
 Before treatment it was found that 95% of 
patients presented with breast tenderness /swelling 
and acne which reduced after treatment and follow 
up period. 90% presented with headache before 
treatment, which reduced after treatment and follow 
up period. 85% presented with swelling of 
extremities before treatment; 75% with joint/muscle 
pain and anger before treatment, which reduced after 
treatment and follow up period. 70% with moderate 
sugar/salt craving before treatment, which reduced 
after treatment and follow up period. 65% with 
moderate infection, social withdrawal and mood 
swing before treatment; which reduced after 
treatment and follow up period. 50% with sexual 
disturbances before treatment, which reduced after 
treatment and follow up period. There is also 
significant reduction in symptoms such as general 
ache and pain, confusion, white discharge. 
Discussion on Probable Mode of Action of Drug 
 While considering Punarnavadi kashaya, majority 
of drugs found to have Kashaya katu tikta rasa, 
Laghu rooksha guna, Ushna veerya and Katu 
vipaka. Remaining drugs found to have Madhura 
amla rasa, Snigdha guna, Seeta veerya and 
Madhura vipaka, hence can be considered as 
Tridosha samana. 
 The drug Punarnava is found to be Sotha 
soolahara, Aamahahara, Kasa swasahara, 
Nidranasahara, Deepana and Vrishya. 
Researchers have proven that Punarnava is anti-
inflammatory, diuretic, expectorant, 
hepatoprotective, aphrodisiac, anti-inflammatory, 
antidepressant, antiestrogenic, antistress, 
adaptogenic, immunomodulatory, GABergic and 
serotogenric[6]. These properties of Punarnava 
normalizes serum potassium levels, hormonal 
fluctuations, neurotransmitter response, RAAS 
and psychological involvement of PMS. 
Considering Nimba, it is Soolahara, Aanahahara 
and is anti-inflammatory, antiarthritic and 
immunostimulant. Patola is Vrishya, Agnideepana, 
Kusta kanduhara. Sunti is Soolahara, 
Aadhmanahara, Kasaswasahara, Sophahara, 
Vibandahara, Kushtahara, Agnimandhyahara and 
it is anti-inflammatory, anti-microbial, anti-
oxidant, antibacterial. It is found to be effective in 
the reduction of severity of mood, physical and 
behavioural symptoms of PMS. The drug Tikta is 
Kasa swasahara and Krimihara. The drug Amrita 
is Medhya deepaneeya, Kandughna, Agnideepana 
and Kasa swasahara. It is found to be anti-
rheumatic, diuretic, anti-inflammatory, anti-
oxidant, anti-allergic, immunomodulatory, 
antistress and anti-ulcerogenic. The drug Darvi is 
Kandughna, Sophaghna, Krimihara, 
Kasaswasahara and is anti-bacterial, anti-
spasmodic and cardio tonic[10]. Owing to above 
said properties of drugs of Punarnavadi kashaya 
and since Punarnavadi kashaya is Tridosha 
samana, it can act on pathogenesis involved and 
can reduce symptom complex involved in PMS. 
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 While considering Aswagandha choornam is 
Tridoshara mainly Vatakaphahara, Sophahara, 
Balya, Vyadhinasana, Nidranasahara, Rasayana, 
Kasaswasahara. Researches proved that it has 
adaptogenic action, GABergic effect, serotogenric 
effect, phytoestrogenic effect, adrenal 
rejuvenating effect, Anxiolytic, cognitive 
enhancing effect, Cardiorespiratory endurant, 
mood stabilizer, sleep enhancing, memory 
booster, antiarthritic, antimicrobial, anti-
inflammatory effect[7]. Owing to these properties, 
Aswagandha choorna is highly beneficial in 
reducing physical, behavioural and psychological 
symptoms of PMS. 
CONCLUSION 
 Premenstrual syndrome is a common 
condition of young and middle aged women having 
distressing physical, psychological and behavioural 
symptoms of sufficient severity to result in 
deterioration of interpersonal relationships and 
interfere with normal activities. Though PMS is not 
life threatening, it can impose significant burden on 
social, physical activities, impact on psychological 
wellbeing and overall quality of life. Even though 
biological factors contributes main etiology of PMS, 
improper lifestyle practices, dietary factors, 
psychological stress and sociocultural factors, plays a 
major role in predisposing PMS. The physical, 
behavioural and psychological symptoms of PMS can 
be very well explained in terms of Doshic imbalance 
and impairment of Manas. So the treatment should 
aim on normalizing Tridoshas and to increase Satwa. 
Modifications in dietary factors and lifestyle, 
encouraging physical activities, psychological 
education and support etc. have a major role in the 
treatment aspect. The research drug Punarnavadi 
kashaya and Aswagandha choorna had shown 
effectiveness in the treatment of depressive effect, 
anxiety, fatigue, irritation, depressive thoughts, pain, 
appetite changes, sleep changes, bloating assessed by 
premenstrual scale; Owing to the properties such as 
Tridoshaharatwa, Soolaharatwa, Sothahara and 
Aadhmanahara of Punarnavadi kashaya and 
Tridoshaharatwa, Sophaharatwa, Nidranasahara, 
Vyadhinasana properties of Aswagandha. Both 
research drug showed effectiveness in normalizing 
serum sodium and serum potassium levels. 
Associated premenstrual complaints also subsided. 
So it can be concluded that study drug Punarnavadi 
kashaya and Aswagandha choorna is very much 
effective in treating Premenstrual syndrome. 
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